Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of medication for Parkinson's disease produced by Teva Pharmaceuticals.

Teva Pharmaceuticals supply a range of medicines to treat Parkinson’s disease. We are not aware of any issues with Teva Pharmaceuticals’ supply of these medicines. Teva Pharmaceuticals discontinued amantadine 100 milligram capsules in July 2024, however alternative suppliers remain in stock, and are able to meet patient demand.